Evidence map›Paper›PMID 36798672›Full record

ArticlePathology oncology research : POR2023

FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.

Anke Behnke, Anne Cayre, Giovanna De Maglio, Giuseppe Giannini, Lionel Habran, Marina Tarsitano, Massimiliano Chetta, David Cappellen, Alexandra Lespagnol, Cecile Le Naoures and 8 more

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Integrating ctDNA testing forAdvances in laboratory medicine · 2025
    Review
  4. Advances in laboratory medicine · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 3 countries.

Anke BehnkeCharité-Universitätsmedizin Berlin, Institute of Pathology and Berlin Institute of Health, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Anne CayreDépartement de Pathologie, Centre Jean-Perrin, Clermont-Ferrand, France.
Giovanna De MaglioAzienda Sanitaria Universitaria Friuli Centrale, Pathology Department, Santa Maria della Misericordia Hospital, Udine, Italy.
Giuseppe GianniniDepartment Molecular Medicine, Università di Roma La Sapienza, Rome, Italy.
Lionel HabranAnatomopathology Department, CHU Liège, Liège, Belgium.
Marina TarsitanoDi Laboratorio, A.O.R.N. Cardarelli, Medical Genetics Laboratory, and Ospedale Antonio Cardarelli, U.O.C. di Genetica Medica, Naples, Italy.
Massimiliano ChettaDi Laboratorio, A.O.R.N. Cardarelli, Medical Genetics Laboratory, and Ospedale Antonio Cardarelli, U.O.C. di Genetica Medica, Naples, Italy.
David CappellenService de Biologie des Tumeurs, Centre Hospitalier Universitaire de Bordeaux, Hôpital du Haut Lévêque, Pessac, France.
Alexandra LespagnolCHU de Rennes, Laboratoire de Génétique Somatique des Cancers, Rennes, France.
Cecile Le NaouresCHU de Rennes, Service d'Anatomie et Cytologie Pathologiques, Rennes, France.
Gabriella MassazzaDipartimento Medicina di Laboratorio Anatomia Patologica, ASST Papa Giovanni XXIII, Bergamo, BG, Italy.
Annarita DestroPathology Department, Humanitas Clinical and Research Center-IRCCS, Milan, Italy.
Irina BonzheimInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.
Achim RauInstitute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.
Achim BattmannInstitut für Pathologie und Zytodiagnostik am Krankenhaus Nordwest, Frankfurt, Germany.
Bettina KahInstitut für Hämatopathologie Hamburg, Hamburg, Germany.
Emmanuel WatkinCYPATH, Villeurbanne, France.
Michael HummelCharité-Universitätsmedizin Berlin, Institute of Pathology and Berlin Institute of Health, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Centre Hospitalier Universitaire de Rennes · FRCharité - Universitätsmedizin Berlin · DEUniversity of Tübingen · DEAzienda Unità Sanitaria Locale di Ferrara · ITCentre Jean Perrin · FRDépartement Microbiologie et Chaîne Alimentaire · FRInstitut für Hämatopathologie Hamburg · DEKrankenhaus Nordwest · DEOspedale Papa Giovanni XXIII · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate testing for epidermal growth factor receptor (

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsDNA Mutational AnalysisErbB ReceptorsHumansMutationProspective StudiesReal-Time Polymerase Chain ReactionErbB Receptorsclinical decision-makingDNA mutational analysisepidermal growth factor receptornon-small cell lung cancerturnaround time

Identifiers

PMID36798672
PMCPMC9927408
OpenAlexW4318704268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.